Biotricity, Inc. announced that it has entered into a securities purchase agreement to issue 55 shares of Series B Preferred Stock at a price of $9,090.91 per share for the gross proceeds of $500,000.05 on June 21, 2024. The shares will have a coupon rate of 8% and will be convertible at a conversion price of $3.50. The transaction included participation from returning investor, Ionic Ventures, LLC.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.845 USD | +8.95% |
|
+9.59% | -27.04% |
Jul. 10 | Biotricity Adds 60-Site, Multi-State Hospital Cardiac Monitoring Pilot Program | CI |
Jun. 27 | Transcript : Biotricity, Inc., Q4 2024 Earnings Call, Jun 27, 2024 |
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-27.04% | 16.79M | |
-7.97% | 2.95B | |
-0.72% | 186M | |
-18.33% | 78.93M |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. announced that it has received $0.5 million in funding from Ionic Ventures, LLC